The Evaluation of TCI378 and TCI507 Probiotics on Weight-lowering Efficacy in Adults

This is a double-blind and randomized study. Subjects are informed to consume the samples every day for 2 months. The person who is evaluated as overweight by the doctor will be invited to participate in this trial. The efficacy assessment items and questionnaires are collected at every visit of the trial.

Inclusion criteria

• Adults between the ages of 20 and 65 who are willing to sign the consent form of the subject.
• BMI ≥ 24 or male body fat ≥ 25%, female body fat ≥ 30%.
• Those who are not pregnant and are willing to cooperate with contraception during the trial period.
• No history of cardiovascular disease, history of organ transplantation, history of epilepsy or convulsions, liver and kidney disease, malignant tumor, endocrine disease, mental disease, alcohol or drug abuse, or other major organic diseases (according to medical history).

Exclusion criteria

• Pregnant women, people with a history of cardiovascular disease, organ transplantation, epilepsy or convulsions, liver and kidney disease, malignant tumors, endocrine diseases, mental diseases, alcohol or drug abuse, and other major organic diseases (according to medical history).
• No person who has undergone major surgery or bariatric surgery (according to medical history).
• Drugs that affect body fat, waist circumference, or significantly increase weight, such as systemic corticosteroids, tricyclic antidepressants, atypical psychiatric drugs, and mood stability, have been used at present or within 3 months before participating in the screening Drugs (according to medical history).